Skip to main content
    • Aa
    • Aa

Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy

  • Teemu Taipale (a1), Kaisu Pienihäkkinen (a2), Erika Isolauri (a3), Charlotte Larsen (a4), Elke Brockmann (a4), Pentti Alanen (a2), Jorma Jokela (a1) and Eva Söderling (a2)...

The impact of controlled administration of Bifidobacterium animalis subsp. lactis BB-12 (BB-12) on the risk of acute infectious diseases was studied in healthy newborn infants. In this double-blind, placebo-controlled study, 109 newborn 1-month-old infants were assigned randomly to a probiotic group receiving a BB-12-containing tablet (n 55) or to a control group receiving a control tablet (n 54). Test tablets were administered to the infants twice a day (daily dose of BB-12 10 billion colony-forming units) from the age of 1–2 months to 8 months with a novel slow-release pacifier or a spoon. Breastfeeding habits, pacifier use, dietary habits, medications and all signs and symptoms of acute infections were registered. At the age of 8 months, faecal samples were collected for BB-12 determination (quantitative PCR method). The baseline characteristics of the two groups were similar, as was the duration of exclusive breastfeeding. BB-12 was recovered (detection limit log 5) in the faeces of 62 % of the infants receiving the BB-12 tablet. The daily duration of pacifier sucking was not associated with the occurrence of acute otitis media. No significant differences between the groups were observed in reported gastrointestinal symptoms, otitis media or use of antibiotics. However, the infants receiving BB-12 were reported to have experienced fewer respiratory infections (65 v. 94 %; risk ratio 0·69; 95 % CI 0·53, 0·89; P = 0·014) than the control infants. Controlled administration of BB-12 in early childhood may reduce respiratory infections.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy
      Available formats
Corresponding author
*Corresponding author: Dr T. Taipale, fax +358 14 266 2770, email
Hide All
1 Vesa S, Kleemola M, Blomqvist S, et al. (2001) Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age. Pediatr Infect Dis J 20, 574581.
2 Alho OP, Koivu M, Sorri M, et al. (1991) The occurrence of acute otitis media in infants. A life-table analysis. Int J Pediatr Otorhinolaryngol 21, 714.
3 Kilpi T, Kero J, Jokinen J, et al. (2002) Common respiratory infections early in life may reduce the risk of atopic dermatitis. Clin Infect Dis 34, 620626.
4 Rautava S, Arvilommi H & Isolauri E (2006) Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res 60, 221224.
5 Holt PG & Jones CA (2000) The development of the immune system during pregnancy and early life. Allergy 55, 688697.
6 Gilliland SE, Morelli L & Reid G (2001) Health and Nutritional Properties of Probiotics in Food Including Powder Milk With Live Lactic Acid Bacteria. Rome: WHO. (accessed August 25 2008).
7 Rautava S (2007) Potential use of probiotics in the neonate. Semin Fetal Neonatal Med 12, 4553.
8 Hatakka K & Saxelin M (2008) Probiotics in intestinal and non-intestinal infectious diseases – clinical evidence. Curr Pharm Des 14, 13511367.
9 Floch MH, Walker AW, Guandalini S, et al. (2008) Recommendations for probiotic use - 2008. J Clin Gastroenerol 42, Suppl. 2, 104108.
10 Fukushima Y, Kawata Y, Hara H, et al. (1998) Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 42, 3944.
11 Szajewska H & Mrukowicz JZ (2001) Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 33, Suppl. 2, 1725.
12 Taipale T, Pienihäkkinen K, Alanen P, et al. (2007) Dissolution of xylitol from a food supplement administered with a novel slow-release pacifier: preliminary results. Eur Arch Paediatr Dent 8, 123125.
13 Saavedra JM, Abi-Hanna A, Moore N, et al. (2004) Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 79, 261267.
14 Hatakka K, Blomgren K, Pohjavuori S, et al. (2007) Treatment of acute otitis media with probiotics in otitis-prone children – a double-blind, placebo-controlled randomised study. Clin Nutr 26, 314321.
15 Rautava S, Salminen S & Isolauri E (2009) Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. Br J Nutr 101, 17221726.
16 Agostoni C, Braegger C, Decsi T, et al. (2009) Breast-feeding: a commentary by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr 49, 112125.
17 Hasunen K & Ryynänen S (2005) Infant feeding in Finland 2005. In Reports of the Ministry of Social Affairs and Health, vol. 19, pp. 12362115. Helsinki: Oy Edita Ab.
18 Harmsen HJM, Wildeboer-Veloo ACM, Raangs GC, et al. (2000) Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30, 6167.
19 Weizman Z, Asli G & Alsheikh A (2005) Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115, 59.
20 Leyer GJ, Li S, Mubasher ME, et al. (2009) Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124, E172E179.
21 Isolauri E, Kalliomäki M, Laitinen K, et al. (2008) Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease. Curr Pharm Des 14, 13681375.
22 North K, Fleming P, Golding J, et al. (1999) Pacifier use and morbidity in the first six months of life. Pediatrics 103, E34.
23 Niemelä M, Pihakari O, Pokka T, et al. (2000) Pacifier as a risk factor for acute otitis media: a randomized, controlled trial of parental counselling. Pediatrics 106, 483488.
24 Chaves RG, Lamounier JA & Cesar CC (2007) Factors associated with duration of breastfeeding. J Pediatr (Rio J) 83, 241246.
25 Uhari M, Kontiokari T & Niemelä M (1998) A novel use of xylitol sugar in preventing acute otitis media. Pediatrics 102, 879884.
26 Larsen C, Nielsen S, Kaestel P, et al. (2006) Dose-response study of probiotic bacteria Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus paracasei subsp. paracasei CRL-341 in healthy young adults. Eur J Clin Nutr 60, 12841293.
27 Grönlund MM, Gueimonde M, Laitinen K, et al. (2007) Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy 37, 17641772.
28 Saxelin M, Pessi T & Salminen S (1995) Fecal recovery following oral administration of Lactobacillus Strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. Int J Food Microbiol 25, 199203.
29 Isolauri E, Rautava S, Kalliomäki M, et al. (2002) Role of probiotics in food hypersensitivity. Curr Opin Allergy Clin Immunol 2, 263271.
30 Gibson GR & Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125, 14011412.
31 Mäkeläinen HS, Mäkivuokko HA, Salminen SJ, et al. (2007) The effects of polydextrose and xylitol on microbial community and activity in a 4-stage colon simulator. J Food Sci 72, M153M159.
32 Aaltonen AS, Suhonen JT, Tenovuo J, et al. (2000) Efficacy of a slow-release device containing fluoride, xylitol and sorbitol in preventing infant caries. Acta Odontol Scand 58, 285292.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 19
Total number of PDF views: 270 *
Loading metrics...

Abstract views

Total abstract views: 523 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 20th October 2017. This data will be updated every 24 hours.